369 related articles for article (PubMed ID: 12533193)
21. Polybenzamide mustards: structure-activity relationships for DNA sequence-specific alkylation.
Turner PR; Ferguson LR; Denny WA
Anticancer Drug Des; 1999 Feb; 14(1):61-70. PubMed ID: 10363028
[TBL] [Abstract][Full Text] [Related]
22. Aspirin and ibuprofen enhance pyrazinamide treatment of murine tuberculosis.
Byrne ST; Denkin SM; Zhang Y
J Antimicrob Chemother; 2007 Feb; 59(2):313-6. PubMed ID: 17185297
[TBL] [Abstract][Full Text] [Related]
23. Regioselective reaction: synthesis and pharmacological study of Mannich bases containing ibuprofen moiety.
Sujith KV; Rao JN; Shetty P; Kalluraya B
Eur J Med Chem; 2009 Sep; 44(9):3697-702. PubMed ID: 19427713
[TBL] [Abstract][Full Text] [Related]
24. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis.
Gengo FM; Rubin L; Robson M; Rainka M; Gengo MF; Mager DE; Bates V
J Clin Pharmacol; 2008 Jan; 48(1):117-22. PubMed ID: 18094224
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs.
Biskupiak JE; Brixner DI; Howard K; Oderda GM
J Pain Palliat Care Pharmacother; 2006; 20(3):7-14. PubMed ID: 16931473
[TBL] [Abstract][Full Text] [Related]
26. Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population.
García Rodríguez LA; Varas-Lorenzo C; Maguire A; González-Pérez A
Circulation; 2004 Jun; 109(24):3000-6. PubMed ID: 15197149
[TBL] [Abstract][Full Text] [Related]
27. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect.
Chattopadhyay M; Kodela R; Nath N; Dastagirzada YM; Velázquez-Martínez CA; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):715-22. PubMed ID: 22222427
[TBL] [Abstract][Full Text] [Related]
28. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
29. Molecular properties and antibacterial activity of the methyl and ethyl ester derivatives of ampicillin.
Bartzatt R; Cirillo SL; Cirillo JD
Physiol Chem Phys Med NMR; 2004; 36(2):85-94. PubMed ID: 16268120
[TBL] [Abstract][Full Text] [Related]
30. [Synthesis and antitumor activity of benzoic nitrogen mustard derivatives].
Luo W; Zhao YM; Wang YX; Xie SQ; Zhao J; Wang CJ
Yao Xue Xue Bao; 2007 Dec; 42(12):1327-9. PubMed ID: 18338650
[TBL] [Abstract][Full Text] [Related]
31. Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT).
Springer CJ; Dowell R; Burke PJ; Hadley E; Davis DH; Blakey DC; Melton RG; Niculescu-Duvaz I
J Med Chem; 1995 Dec; 38(26):5051-65. PubMed ID: 8544182
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
Atwell GJ; Yang S; Pruijn FB; Pullen SM; Hogg A; Patterson AV; Wilson WR; Denny WA
J Med Chem; 2007 Mar; 50(6):1197-212. PubMed ID: 17326614
[TBL] [Abstract][Full Text] [Related]
33. Two lead drug designs based on chloramphenicol as the parent structure, which express alkylation activity with potential for clinical applications.
Bartzatt R
J Pharm Pharmacol; 2003 May; 55(5):653-60. PubMed ID: 12831508
[TBL] [Abstract][Full Text] [Related]
34. Commercially viable resolution of ibuprofen.
Chávez-Flores D; Salvador JM
Biotechnol J; 2009 Aug; 4(8):1222-4. PubMed ID: 19455529
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
[TBL] [Abstract][Full Text] [Related]
37. NO-NSAIDs: Gastric-sparing nitric oxide-releasable prodrugs of non-steroidal anti-inflammatory drugs.
Nemmani KV; Mali SV; Borhade N; Pathan AR; Karwa M; Pamidiboina V; Senthilkumar SP; Gund M; Jain AK; Mangu NK; Dubash NP; Desai DC; Sharma S; Satyam A
Bioorg Med Chem Lett; 2009 Sep; 19(18):5297-301. PubMed ID: 19683923
[TBL] [Abstract][Full Text] [Related]
38. Potential anticancer agents. XVII. New developments in the benzoic acid nitrogen mustards area.
Niculescu-Duvăz I; Feyns V; Dobre V
Cancer Treat Rep; 1978 Dec; 62(12):2045-54. PubMed ID: 751714
[TBL] [Abstract][Full Text] [Related]
39. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen.
Giagoudakis G; Markantonis SL
Pharmacotherapy; 2005 Jan; 25(1):18-25. PubMed ID: 15767216
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, pharmacological activity and hydrolytic behavior of ethylenediamine and benzathine conjugates of ibuprofen.
Chatterjee NR; Kulkarni AA; Ghulekar SP
Eur J Med Chem; 2008 Dec; 43(12):2819-23. PubMed ID: 18068271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
